562 related articles for article (PubMed ID: 8551565)
21. Vaccination protects beta 2 microglobulin deficient mice from immune mediated mortality but not from persisting viral infection.
Hildeman D; Salvato M; Whitton JL; Muller D
Vaccine; 1996 Sep; 14(13):1223-9. PubMed ID: 8961509
[TBL] [Abstract][Full Text] [Related]
22. CD40L expression by CD4
Durlanik S; Loyal L; Stark R; Sercan Alp Ö; Hartung A; Radbruch A; von Herrath M; Matzmohr N; Frentsch M; Thiel A
Eur J Immunol; 2016 Nov; 46(11):2566-2573. PubMed ID: 27562840
[TBL] [Abstract][Full Text] [Related]
23. Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus.
Moskophidis D; Zinkernagel RM
J Virol; 1995 Apr; 69(4):2187-93. PubMed ID: 7533851
[TBL] [Abstract][Full Text] [Related]
24. Loss of Resistance to Mousepox during Chronic Lymphocytic Choriomeningitis Virus Infection Is Associated with Impaired T-Cell Responses and Can Be Rescued by Immunization.
Alves-Peixoto P; Férez M; Knudson CJ; Melo-Silva CR; Stotesbury C; Wong EB; Correia-Neves M; Sigal LJ
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826990
[TBL] [Abstract][Full Text] [Related]
25. T regulatory cells are critical for the maintenance, anamnestic expansion and protection elicited by vaccine-induced CD8 T cells.
Bhattacharyya M; Penaloza-MacMaster P
Immunology; 2017 Jul; 151(3):340-348. PubMed ID: 28295248
[TBL] [Abstract][Full Text] [Related]
26. Protective CTL-dependent immunity and enhanced immunopathology in mice immunized by particle bombardment with DNA encoding an internal virion protein.
Zarozinski CC; Fynan EF; Selin LK; Robinson HL; Welsh RM
J Immunol; 1995 Apr; 154(8):4010-7. PubMed ID: 7706740
[TBL] [Abstract][Full Text] [Related]
27. Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice.
van der Most RG; Murali-Krishna K; Whitton JL; Oseroff C; Alexander J; Southwood S; Sidney J; Chesnut RW; Sette A; Ahmed R
Virology; 1998 Jan; 240(1):158-67. PubMed ID: 9448700
[TBL] [Abstract][Full Text] [Related]
28. Vaccination against lymphocytic choriomeningitis virus infection in MHC class II-deficient mice.
Holst PJ; Christensen JP; Thomsen AR
J Immunol; 2011 Apr; 186(7):3997-4007. PubMed ID: 21357263
[TBL] [Abstract][Full Text] [Related]
29. Enhanced establishment of a virus carrier state in adult CD4+ T-cell-deficient mice.
Battegay M; Moskophidis D; Rahemtulla A; Hengartner H; Mak TW; Zinkernagel RM
J Virol; 1994 Jul; 68(7):4700-4. PubMed ID: 7911534
[TBL] [Abstract][Full Text] [Related]
30. Depletion of CD4+ T cells precipitates immunopathology in immunodeficient mice infected with a noncytocidal virus.
Christensen JP; Bartholdy C; Wodarz D; Thomsen AR
J Immunol; 2001 Mar; 166(5):3384-91. PubMed ID: 11207295
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow contains virus-specific cytotoxic T lymphocytes.
Slifka MK; Whitmire JK; Ahmed R
Blood; 1997 Sep; 90(5):2103-8. PubMed ID: 9292550
[TBL] [Abstract][Full Text] [Related]
32. T cell memory. Long-term persistence of virus-specific cytotoxic T cells.
Jamieson BD; Ahmed R
J Exp Med; 1989 Jun; 169(6):1993-2005. PubMed ID: 2471771
[TBL] [Abstract][Full Text] [Related]
33. Infection of lymphocytes by a virus that aborts cytotoxic T lymphocyte activity and establishes persistent infection.
Borrow P; Tishon A; Oldstone MB
J Exp Med; 1991 Jul; 174(1):203-12. PubMed ID: 1905339
[TBL] [Abstract][Full Text] [Related]
34. Virus-induced polyclonal B cell activation improves protective CTL memory via retained CD27 expression on memory CTL.
Matter M; Mumprecht S; Pinschewer DD; Pavelic V; Yagita H; Krautwald S; Borst J; Ochsenbein AF
Eur J Immunol; 2005 Nov; 35(11):3229-39. PubMed ID: 16231287
[TBL] [Abstract][Full Text] [Related]
35. Memory CD8+ T cells in heterologous antiviral immunity and immunopathology in the lung.
Chen HD; Fraire AE; Joris I; Brehm MA; Welsh RM; Selin LK
Nat Immunol; 2001 Nov; 2(11):1067-76. PubMed ID: 11668342
[TBL] [Abstract][Full Text] [Related]
36. Induction of protective cytotoxic T cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunization.
Seiler P; Bründler MA; Zimmermann C; Weibel D; Bruns M; Hengartner H; Zinkernagel RM
J Exp Med; 1998 Feb; 187(4):649-54. PubMed ID: 9463415
[TBL] [Abstract][Full Text] [Related]
37. Virus-specific, CD8+ major histocompatibility complex class I-restricted cytotoxic T lymphocytes in lymphocytic choriomeningitis virus-infected beta2-microglobulin-deficient mice.
Quinn DG; Zajac AJ; Hioe CE; Frelinger JA
J Virol; 1997 Nov; 71(11):8392-6. PubMed ID: 9343195
[TBL] [Abstract][Full Text] [Related]
38. Adenovirus Serotype 5 Vaccination Results in Suboptimal CD4 T Helper 1 Responses in Mice.
Lee J; Hashimoto M; Im SJ; Araki K; Jin HT; Davis CW; Konieczny BT; Spies GA; McElrath MJ; Ahmed R
J Virol; 2017 Mar; 91(5):. PubMed ID: 28003483
[TBL] [Abstract][Full Text] [Related]
39. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections.
Brehm MA; Markees TG; Daniels KA; Greiner DL; Rossini AA; Welsh RM
J Immunol; 2003 Apr; 170(8):4077-86. PubMed ID: 12682237
[TBL] [Abstract][Full Text] [Related]
40. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
